melapuldencel-T (DC-TC)
/ Lisata Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 10, 2019
Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma
(clinicaltrials.gov)
- P3; N=4; Terminated; Sponsor: Caladrius Biosciences, Inc.; N=250 ➔ 4
Enrollment change
1 to 1
Of
1
Go to page
1